Bioiberica joins a European project to develop treatments for complex wounds
Bioiberica has joined the NABIHEAL project funded by the Horizon Europe programme, coordinated by the Centre for Biomedical Research Network (CIBER).
The aim of this project, which has been awarded top EU status, is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a game-changing alternative to current treatments used in wound-healing dressings. In the project, Bioiberica will contribute its knowledge of the biologically-derived ingredients needed to develop the biomaterials.
NABIHEAL aims at solving two currently unmet medical needs in the healing of complex wounds: affordable treatments for wound infections and to prevent complications during healing; and a strategy to optimise the composition and efficacy of wound healing drugs and dressings.
The international consortium consists of 14 partners from 7 countries, including research centres, universities and private companies.
In addition to Bioiberica, participating in this project are the Centre for Biomedical Research Network (CIBER) at the Institute of Materials Science of Barcelona (ICMAB), as coordinator, the Centre for Biomedical Research Network (CIBER) at the University of Extremadura and the University of Cantabria, the Spanish National Research Council (CSIC), Nanomol Technologies S.L., Histocell S.L., the University of Granada and Asphalion, MyBiotech GmbH and Charité-Universitätsmedizin Berlin (Germany), the Institute for Medical Research and Occupational Health (Croatia), the University of Aarhus (Denmark), the Technion-Israel Institute of Technology (Israel), BioNanoNet Forschungsgesellschaft mbH (Austria) and the University of Maribor (Slovenia).
If you want to know more about our R&D partnerships in Bioiberica, click here.